Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/26 17:03 | 9/14/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Boyer David W. | CA | O | Chief Co | 1 | S | -130 | 157.45 | 0 | -1 | 9 | D | |||||||||||||||
9/15/26 17:02 | 9/14/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Abernethy Matt | CA | O | CFO | 1 | S | -363 | 157.20 | 0 | -2 | 43 | D | |||||||||||||||
9/10/26 20:29 | 9/9/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Benevich Eric | CA | O | Chief Co | 2 | M.d | 471 | 88.10 | 0 | 5 | 9 | 64 | D | ||||||||||||||
9/10/26 20:29 | 9/9/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Benevich Eric | CA | O | Chief Co | 2 | S.d | -471 | 88.10 | 0 | -5 | 64 | D | |||||||||||||||
7/30/26 17:29 | 7/28/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Norwalk Leslie V | CA | D | 2 | S.d | -345 | 164.87 | 0 | -2 | 2 | D | ||||||||||||||||
7/30/26 17:29 | 7/29/26 | NBIX | Health | BioPrd | Biological Products, (No Diag | Norwalk Leslie V | CA | D | 2 | M.d | 345 | 164.87 | 0 | 2 | 619 | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |